93 related articles for article (PubMed ID: 9625114)
1. Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal acid reflux in patients with Barrett's esophagus.
Ouatu-Lascar R; Triadafilopoulos G
Am J Gastroenterol; 1998 May; 93(5):711-6. PubMed ID: 9625114
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of medical therapy and antireflux surgery to prevent Barrett's metaplasia in patients with gastroesophageal reflux disease.
Wetscher GJ; Gadenstaetter M; Klingler PJ; Weiss H; Obrist P; Wykypiel H; Klaus A; Profanter C
Ann Surg; 2001 Nov; 234(5):627-32. PubMed ID: 11685025
[TBL] [Abstract][Full Text] [Related]
3. Duodeno-gastric-esophageal reflux--what is pathologic? Comparison of patients with Barrett's esophagus and age-matched volunteers.
Wolfgarten E; Pütz B; Hölscher AH; Bollschweiler E
J Gastrointest Surg; 2007 Apr; 11(4):479-86. PubMed ID: 17436133
[TBL] [Abstract][Full Text] [Related]
4. Intraluminal pH and goblet cell density in Barrett's esophagus.
Theodorou D; Ayazi S; DeMeester SR; Zehetner J; Peyre CG; Grant KS; Augustin F; Oh DS; Lipham JC; Chandrasoma PT; Hagen JA; DeMeester TR
J Gastrointest Surg; 2012 Mar; 16(3):469-74. PubMed ID: 22095525
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of acid reflux in Barrett's esophagus.
Xu J; Chen J; Hou X
J Huazhong Univ Sci Technolog Med Sci; 2002; 22(3):235-6, 264. PubMed ID: 12658814
[TBL] [Abstract][Full Text] [Related]
6. Medical or surgical management of GERD patients with Barrett's esophagus: the LOTUS trial 3-year experience.
Attwood SE; Lundell L; Hatlebakk JG; Eklund S; Junghard O; Galmiche JP; Ell C; Fiocca R; Lind T
J Gastrointest Surg; 2008 Oct; 12(10):1646-54; discussion 1654-5. PubMed ID: 18709511
[TBL] [Abstract][Full Text] [Related]
7. [Use of flexible transnasal esophagogastroscopy in patients with unclear globus sensation].
Podzimek J; Jecker P; Koscielny S; Guntinas-Lichius O
HNO; 2024 Apr; ():. PubMed ID: 38592479
[TBL] [Abstract][Full Text] [Related]
8. Bile reflux is associated with Barrett's esophagus.
Li Z; Yang K
Dig Liver Dis; 2024 Jun; 56(6):1107-1108. PubMed ID: 38195347
[No Abstract] [Full Text] [Related]
9. Lifestyle Risk Factors, Quality of Life, and Intervention Preferences of Barrett's Esophagus Patients: A Prospective Cohort Study.
Zhang X; Anandasabapathy S; Abrams J; Othman M; Badr HJ
Glob Adv Health Med; 2021; 10():21649561211001346. PubMed ID: 33767920
[TBL] [Abstract][Full Text] [Related]
10. Magnetic sphincter augmentation: considerations for use in Barrett's esophagus.
Reiter AJ; Farina DA; Fronza JS; Komanduri S
Dis Esophagus; 2023 Jun; 36(Supplement_1):. PubMed ID: 36575922
[TBL] [Abstract][Full Text] [Related]
11. The TEMPO Trial at 5 Years: Transoral Fundoplication (TIF 2.0) Is Safe, Durable, and Cost-effective.
Trad KS; Barnes WE; Prevou ER; Simoni G; Steffen JA; Shughoury AB; Raza M; Heise JA; Fox MA; Mavrelis PG
Surg Innov; 2018 Apr; 25(2):149-157. PubMed ID: 29405886
[TBL] [Abstract][Full Text] [Related]
12. Response to TNF-α Is Increasing Along with the Progression in Barrett's Esophagus.
Chemnitzer O; Götzel K; Maurer L; Dietrich A; Eichfeld U; Lyros O; Jansen-Winkeln B; Hoffmeister A; Gockel I; Thieme R
Dig Dis Sci; 2017 Dec; 62(12):3391-3401. PubMed ID: 29086334
[TBL] [Abstract][Full Text] [Related]
13. Impact of gastroesophageal reflux control through tailored proton pump inhibition therapy or fundoplication in patients with Barrett's esophagus.
Baldaque-Silva F; Vieth M; Debel M; Håkanson B; Thorell A; Lunet N; Song H; Mascarenhas-Saraiva M; Pereira G; Lundell L; Marschall HU
World J Gastroenterol; 2017 May; 23(17):3174-3183. PubMed ID: 28533674
[TBL] [Abstract][Full Text] [Related]
14. Proton Pump Inhibitors Display Antitumor Effects in Barrett's Adenocarcinoma Cells.
Chueca E; Apostolova N; Esplugues JV; García-González MA; Lanas Á; Piazuelo E
Front Pharmacol; 2016; 7():452. PubMed ID: 27932981
[TBL] [Abstract][Full Text] [Related]
15. Unmet Needs in the Treatment of Gastroesophageal Reflux Disease.
Dickman R; Maradey-Romero C; Gingold-Belfer R; Fass R
J Neurogastroenterol Motil; 2015 Jul; 21(3):309-19. PubMed ID: 26130628
[TBL] [Abstract][Full Text] [Related]
16. Control of acid and duodenogastroesophageal reflux (DGER) in patients with Barrett's esophagus.
Yachimski P; Maqbool S; Bhat YM; Richter JE; Falk GW; Vaezi MF
Am J Gastroenterol; 2015 Aug; 110(8):1143-8. PubMed ID: 26032153
[TBL] [Abstract][Full Text] [Related]
17. Managing Barrett's esophagus with radiofrequency ablation.
Akiyama J; Roorda A; Triadafilopoulos G
Gastroenterol Rep (Oxf); 2013 Sep; 1(2):95-104. PubMed ID: 24759814
[TBL] [Abstract][Full Text] [Related]
18. Transoral incisionless fundoplication effective in eliminating GERD symptoms in partial responders to proton pump inhibitor therapy at 6 months: the TEMPO Randomized Clinical Trial.
Trad KS; Barnes WE; Simoni G; Shughoury AB; Mavrelis PG; Raza M; Heise JA; Turgeon DG; Fox MA
Surg Innov; 2015 Feb; 22(1):26-40. PubMed ID: 24756976
[TBL] [Abstract][Full Text] [Related]
19. Heartburn, Barrett's oesophagus and cancer: implications for primary care.
Watson A; Galloway J
Br J Gen Pract; 2014 Mar; 64(620):120-1. PubMed ID: 24567627
[No Abstract] [Full Text] [Related]
20. Barrett's oesophagus: epidemiology, cancer risk and implications for management.
de Jonge PJ; van Blankenstein M; Grady WM; Kuipers EJ
Gut; 2014 Jan; 63(1):191-202. PubMed ID: 24092861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
